Literature DB >> 18475472

Release of adenosine from human neutrophils stimulated by platelet activating factor, leukotriene B(4) and opsonized zymosan.

S Sipka1, Z Dinya, M Koltai, P Braquet, G Szegedi.   

Abstract

Isolated human polymorphonuclear leukocytes (PMNL) stimulated by platelet activating factor (PAF), leukotriene B(4) (LTB(4)) or opsonized zymosan (OZ) released adenosine measured by thermospray high performance liquid chromatography mass spectrometry in the cell-free supernatants. Stimulation by PAF or LTB(4) resulted in a bellshaped concentration-effect curve; 5 x 10(-7) M PAF, 10(-8) M LTB(4) and 500 mug ml(-1) OZ induced peak adenosine release, thus cytotoxic concentrations did not elevate adenosine level in the supernatants. Therefore adenosine release was characteristic of viable cells. As calculated from concentration-effect curves, the rank order of potency for adenosine release was PAF > LTB > OZ. These resuits suggest that adenosine, when bound specifically to membrane receptor sites, may initiate signal transduction, and, in co-operation with other inflammatory mediators, may modulate phagocyte function, e.g. production of chemoluminescence (CL).

Entities:  

Year:  1992        PMID: 18475472      PMCID: PMC2365349          DOI: 10.1155/S0962935192000413

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  37 in total

Review 1.  Interactions between second messengers: cyclic AMP and phospholipase A2- and phospholipase C-metabolites.

Authors:  V Di Marzo; S H Galadari; J R Tippins; H R Morris
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

2.  Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.

Authors:  R J Haslam; M M Davidson; J V Desjardins
Journal:  Biochem J       Date:  1978-10-15       Impact factor: 3.857

3.  Leukotriene B4 is a complete secretagogue in human neutrophils: a kinetic analysis.

Authors:  C N Serhan; A Radin; J E Smolen; H Korchak; B Samuelsson; G Weissmann
Journal:  Biochem Biophys Res Commun       Date:  1982-08       Impact factor: 3.575

4.  Protein kinase C and cyclic AMP modulate thrombin-induced platelet-activating factor synthesis in human endothelial cells.

Authors:  R Heller; F Bussolino; D Ghigo; G Garbarino; H Schröder; G Pescarmona; U Till; A Bosia
Journal:  Biochim Biophys Acta       Date:  1991-06-07

5.  The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively.

Authors:  B N Cronstein; L Daguma; D Nichols; A J Hutchison; M Williams
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

6.  Granulocyte-macrophage colony-stimulating factor increases the synthesis of leukotriene B4 by human neutrophils in response to platelet-activating factor. Enhancement of both arachidonic acid availability and 5-lipoxygenase activation.

Authors:  S R McColl; E Krump; P H Naccache; P E Poubelle; P Braquet; M Braquet; P Borgeat
Journal:  J Immunol       Date:  1991-02-15       Impact factor: 5.422

7.  Modulation of human platelet adenylate cyclase by prostacyclin (PGX).

Authors:  R R Gorman; S Bunting; O V Miller
Journal:  Prostaglandins       Date:  1977-03

8.  Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets.

Authors:  J E Tateson; S Moncada; J R Vane
Journal:  Prostaglandins       Date:  1977-03

9.  Adenosine in the local regulation of blood flow: a brief overview.

Authors:  R M Berne; R M Knabb; S W Ely; R Rubio
Journal:  Fed Proc       Date:  1983-12

10.  Presence of adenosine deaminase on the surface of mononuclear blood cells: immunochemical localization using light and electron microscopy.

Authors:  J M Aran; D Colomer; E Matutes; J L Vives-Corrons; R Franco
Journal:  J Histochem Cytochem       Date:  1991-08       Impact factor: 2.479

View more
  1 in total

1.  Tumour necrosis factor-alpha and adenosine in endotoxin shockleading related cardiovascular symptoms.

Authors:  S Sipka; T Seres; Z Dinya; Z Szekanecz; J Szentmiklósi; E Bodolay; G Szegedi
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.